Analysts at Piper Jaffray downgraded Imax IMAX from Overweight to Neutral.
The target price for Imax has been lowered from $35 to $28.
Imax shares have gained 1.89% over the past 52 weeks, while the S&P 500 index has jumped 17.39% in the same period.
Imax's shares dropped 3.07% to close at $25.87 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in